Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2003
10/07/2003US6630495 Compound containing 2-pyridyl or its N-oxide
10/07/2003US6630489 Quinoline derivatives as tyrosine kinase inhibitors
10/07/2003US6630469 5-HT7 receptor antagonists
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630461 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
10/07/2003CA2244402C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
10/07/2003CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays
10/07/2003CA2107105C Heterocyclic-cyclic amine derivatives
10/02/2003WO2003080603A1 Benzodiazepine derivative
10/02/2003WO2003080602A1 Maleic acid salt of (2s)-n-{5-[amino(imino)methyl]-2-thienyl}methyl-1-{(2r)-2-[(carboxymethyl)amino]3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for
10/02/2003WO2003080601A1 New crystalline forms of (2s)-n-5-[amino(imino)methyl]-2-thienylmethyl-1-(2r)-2-[(carboxymethyl)amino]-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080577A2 Amidoacetonitrile compounds
10/02/2003WO2003080573A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080042A1 Decomposition inhibitor for extracellular matrix of cartilage
10/02/2003WO2003039529A8 Selective antibacterial agents
10/02/2003WO2003010160A3 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists
10/02/2003US20030187266 Non-nucleoside reverse transcriptase inhibitors
10/02/2003US20030187258 Bactericides
10/02/2003US20030187235 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
10/02/2003US20030187182 Novel electrically conductive polymer, sensor using the same, and method for detecting target molecule using the sensor
10/02/2003US20030187061 Antitumor agnets; antileukemia agents
10/02/2003US20030187060 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same
10/02/2003US20030187059 Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
10/02/2003US20030187053 Eating disorders; antilipemic agents; anticholesterol agents; cardiovascular disorders
10/02/2003US20030187050 Crystal structure; stability; bioavailability
10/02/2003US20030187026 Antiproliferative agents
10/02/2003US20030187023 Sulfone derivatives, process for their production and use thereof
10/02/2003US20030187022 Pain management; analgesics
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030187004 Central nervous system disorders; Alzheimer's disease
10/02/2003US20030187002 Antiproliferative agents; anticancer agents
10/02/2003US20030186984 Substituted cyclohexane derivatives
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186976 Benzofurylpyrone derivatives
10/02/2003US20030186969 Benzodiazepine derivatives
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186963 Central nervous system disorders; cardiovascular disorders
10/02/2003US20030186962 Cysteine protease inhibitors
10/02/2003US20030186961 Central nervous system disorders; vision defects
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030183812 Fluorinated crosslinked electro-optic materials and electro-optic devices therefrom
10/02/2003CA2761440A1 Fredericamycin derivatives
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2479893A1 Maleic acid salt of (2s)-n-{5-¬amino(imino)methyl|-2-thienyl}methyl-1-{(2r)-2-¬(carboxymethyl)amino|3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for preparing the same
10/02/2003CA2479888A1 New crystalline forms of (2s)-n-5-¬amino(imino)methyl|-2-thienylmethyl-1-(2r)-2-¬(carboxymethyl)amino|-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
10/02/2003CA2477771A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1204655B1 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
10/01/2003EP1200423B1 Substituted phenyl uracils
10/01/2003EP0944595B1 5-cyclo indole compounds as 5-ht1d receptor ligands
10/01/2003EP0891331B1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446048A N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
10/01/2003CN1445226A New cornpound derivated from quinazoline, itd preparation method and medicinal composite containig them
10/01/2003CN1445211A New amide ramification of sweetsop as well as its preparing method, its medication composition and usage
10/01/2003CN1122667C Process for preparing N6-substituted deaza adenosine derivatives
10/01/2003CN1122666C New 2,3-dioxide indanol compounds, process for their preparation and pharmaceutical compositions containing them
09/2003
09/30/2003US6627683 Curing cyclic hydrocarbon including oxirane or thiirane moiety joined by (thio)ester by exposure to heat and decomposition; polyepoxides and polythioepoxides
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627651 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human
09/30/2003US6627650 An isomer thereof, or an addition salt thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti- cancer agents.
09/30/2003US6627645 Muscarinic agonists
09/30/2003US6627644 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
09/30/2003US6627629 Useful for the treatment or prevention of asthma and other allergic diseases.
09/30/2003US6627624 Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome,
09/30/2003US6627611 C-glycosides and preparation of thereof as antidiabetic agents
09/25/2003WO2003079403A2 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003WO2003078421A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003078416A1 Therapeutic ion channel blocking agents and methods of use thereof
09/25/2003WO2003078403A2 Derives d’aminoindazoles comme inhibiteurs de proteine-kinase
09/25/2003WO2003078402A1 Indazoles substituted with an anti-cancerous activity
09/25/2003WO2003078398A1 NON-PEPTIDE GnRH ANTAGONISTS
09/25/2003WO2003078397A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
09/25/2003WO2003078395A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003077921A1 Azinylaminoazoles as inhibitors of protein kinases
09/25/2003WO2003077918A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
09/25/2003WO2003077913A1 Peptide deformylase inhibitors
09/25/2003WO2003077910A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003WO2003077907A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003WO2003077874A2 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003077656A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
09/25/2003WO2002060392A3 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
09/25/2003US20030181482 Antitumor agents, anticarcinogenic agents, a 3-oxoacetamideindolyl compounds, for treating cancer, cytotoxic, and angiogensis inhibitors
09/25/2003US20030181481 Therapeutic drugs for treating central nervous system disorders
09/25/2003US20030181465 Pyrimidines as novel openers of potassium ion channels
09/25/2003US20030181446 Novel N-acylated heterocycles
09/25/2003US20030181440 Isonipecotamides for the treatment of integrin-mediated disorders
09/25/2003US20030181420 Modulators of LXR
09/25/2003CA2479481A1 Therapeutic ion channel blocking agents and methods of use thereof
09/25/2003CA2479266A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003CA2479069A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
09/25/2003CA2478909A1 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 523